Global Head of Biomarkers
mRNA Center of Excellence | Sanofi
Dr. Schanen is Head of Biomarker Research in the mRNA Center of Excellence and helps lead the design and execution of translational clinical research within Sanofi's Vaccines global unit. His team brings innovative approaches to early phase clinical trial research to enhance understanding of mRNA vaccine immunogenicity and reactogenicity. Before this role, Dr. Schanen supported the Translational Science and Biomarker department in the Vaccine Research unit. Joining Sanofi in 2010 via the VaxDesign acquisition, where he contributed to developing 3D human immune tissue constructs since its inception in 2005. Dr. Schanen holds an M.Sc. in biotechnology and a Ph.D. in Immunology and Biomedical Science from the University of Central Florida.
Disclosure information not submitted.
Translational Research Panel: Advancing Discoveries from the Research Bench to the Clinic
Thursday, July 17, 2025
3:00 PM - 4:00 PM EDT
